Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?

Zacks

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Molina Healthcare (MOH) been one of those stocks this year? Let’s take a closer look at the stock’s year-to-date performance to find out.

Molina Healthcare is one of 757 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past three months, the Zacks Consensus Estimate for MOH’s full-year earnings has moved 44.28% higher. This signals that analyst sentiment is improving and the stock’s earnings outlook is more positive.

Based on the most recent data, MOH has returned 80.41% so far this year. Meanwhile, the Medical sector has returned an average of 7.56% on a year-to-date basis. As we can see, Molina Healthcare is performing better than its sector in the calendar year.

Looking more specifically, MOH belongs to the Medical – HMOs industry, which includes 13 individual stocks and currently sits at #20 in the Zacks Industry Rank. Stocks in this group have gained about 22.29% so far this year, so MOH is performing better this group in terms of year-to-date returns.

Investors in the Medical sector will want to keep a close eye on MOH as it attempts to continue its solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Be the first to comment

Leave a Reply